246 related articles for article (PubMed ID: 32003751)
1. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
2. IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.
Fang M; Li Y; Huang K; Qi S; Zhang J; Zgodzinski W; Majewski M; Wallner G; Gozdz S; Macek P; Kowalik A; Pasiarski M; Grywalska E; Vatan L; Nagarsheth N; Li W; Zhao L; Kryczek I; Wang G; Wang Z; Zou W; Wang L
Cancer Res; 2017 May; 77(10):2735-2745. PubMed ID: 28249897
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33/ST2 Signaling Promotes Hepatocellular Carcinoma Cell Stemness Expansion Through Activating c-Jun N-terminal Kinase Pathway.
Zhao R; Yu Z; Li M; Zhou Y
Am J Med Sci; 2019 Oct; 358(4):279-288. PubMed ID: 31420092
[TBL] [Abstract][Full Text] [Related]
4. The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial-mesenchymal transition by phosphorylating β-catenin.
Ruan J; Tian Q; Li S; Zhou X; Sun Q; Wang Y; Xiao Y; Li M; Chang K; Yi X
Cell Commun Signal; 2024 Jun; 22(1):318. PubMed ID: 38858740
[TBL] [Abstract][Full Text] [Related]
5. IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.
Zhang JF; Wang P; Yan YJ; Li Y; Guan MW; Yu JJ; Wang XD
Oncol Rep; 2017 Oct; 38(4):2033-2042. PubMed ID: 28849217
[TBL] [Abstract][Full Text] [Related]
6. IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C.
Zhang JF; Tao T; Wang K; Zhang GX; Yan Y; Lin HR; Li Y; Guan MW; Yu JJ; Wang XD
Sci Rep; 2019 Dec; 9(1):20276. PubMed ID: 31889095
[TBL] [Abstract][Full Text] [Related]
7. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
8. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
[TBL] [Abstract][Full Text] [Related]
10. CD90
Xue BZ; Xiang W; Zhang Q; Wang HF; Zhou YJ; Tian H; Abdelmaksou A; Xue J; Sun MX; Yi DY; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2021 Jul; 12(1):394. PubMed ID: 34256854
[TBL] [Abstract][Full Text] [Related]
11. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
[TBL] [Abstract][Full Text] [Related]
12. IL-33/ST2 Axis in Organ Fibrosis.
Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
Front Immunol; 2018; 9():2432. PubMed ID: 30405626
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis.
Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
15. IL33/ST2 contributes to airway remodeling via p-JNK MAPK/STAT3 signaling pathway in OVA-induced allergic airway inflammation in mice.
Zhang Y; Li S; Huang S; Cao L; Liu T; Zhao J; Wu J; Wang J; Cao L; Xu J; Dong L
Exp Lung Res; 2019; 45(3-4):65-75. PubMed ID: 31112061
[No Abstract] [Full Text] [Related]
16. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
[TBL] [Abstract][Full Text] [Related]
17. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
18. Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Babu D; Mudiraj A; Yadav N; Y B V K C; Panigrahi M; Prakash Babu P
Cell Oncol (Dordr); 2021 Aug; 44(4):889-905. PubMed ID: 33948872
[TBL] [Abstract][Full Text] [Related]
19. A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.
Kwon JW; Seok SH; Kim S; An HW; Choudhury AD; Woo SH; Oh JS; Kim JK; Voon DC; Kim DY; Park JW
Oncogene; 2023 Feb; 42(7):501-515. PubMed ID: 36526851
[TBL] [Abstract][Full Text] [Related]
20. IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway.
Huang N; Cui X; Li W; Zhang C; Liu L; Li J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
